Literature DB >> 32259696

Associations of plasma hypocretin-1 with metabolic and reproductive health: Two systematic reviews of clinical studies.

Galit L Dunietz1, Giancarlo Vanini2, Carol Shannon3, Louise M O'Brien4, Ronald D Chervin5.   

Abstract

The hypocretin system consists of two peptides hypocretin-1 and hypocretin-2 (HCRT1 and HCRT2). Hypocretin-containing neurons are located in the posterior and lateral hypothalamus, and have widespread projections throughout the brain and spinal cord. In addition to its presence in the cerebrospinal fluid (CSF), peripheral HCRT1 has been detected in plasma. Robust experimental evidence demonstrates functions of hypothalamic-originated HCRT1 in regulation of multiple biological systems related to sleep-wake states, energy homeostasis and endocrine function. In contrast, HCRT1 studies with human participants are limited by the necessarily invasive assessment of CSF HCRT1 to patients with underlying morbidity. Regulation by HCRT1 of energy homeostasis and reproduction in animals suggests similar regulation in humans and prompts these two systematic reviews. These reviews translate prior experimental findings from animal studies to humans and examine associations between HCRT1 and: 1) metabolic risk factors; 2) reproductive function in men, women and children. A total of 21 studies and six studies met the inclusion criteria for the two searches, respectively. Research question, study design, study population, assessments of HCRT1, reproductive, cardiometabolic data and main findings were extracted. Associations between HCRT1, metabolic and reproductive function are inconsistent. Limitations of studies and future research directions are outlined.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gonadotropin-releasing hormone; Hypocretin-1; Metabolic health; Narcolepsy; Orexin-A; Overweight; Reproductive hormones

Mesh:

Substances:

Year:  2020        PMID: 32259696      PMCID: PMC7351596          DOI: 10.1016/j.smrv.2020.101307

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  105 in total

1.  Orexin synthesis and response in the gut.

Authors:  A L Kirchgessner; M Liu
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

2.  A selective orexin-1 receptor antagonist reduces food consumption in male and female rats.

Authors:  A C Haynes; B Jackson; H Chapman; M Tadayyon; A Johns; R A Porter; J R Arch
Journal:  Regul Pept       Date:  2000-12-22

Review 3.  Sleep, sleep disturbance, and fertility in women.

Authors:  Jacqueline D Kloss; Michael L Perlis; Jessica A Zamzow; Elizabeth J Culnan; Clarisa R Gracia
Journal:  Sleep Med Rev       Date:  2014-10-18       Impact factor: 11.609

4.  Serum levels of spexin and kisspeptin negatively correlate with obesity and insulin resistance in women.

Authors:  P A Kołodziejski; E Pruszyńska-Oszmałek; E Korek; M Sassek; D Szczepankiewicz; P Kaczmarek; L Nogowski; P Maćkowiak; K W Nowak; H Krauss; M Z Strowski
Journal:  Physiol Res       Date:  2017-11-10       Impact factor: 1.881

5.  Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome.

Authors:  O Tabak; R Gelişgen; H Cicekçi; E Senateş; F Erdenen; C Müderrisoğlu; H Aral; H Uzun
Journal:  Minerva Med       Date:  2012-08       Impact factor: 4.806

6.  Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats.

Authors:  O Jöhren; S J Neidert; M Kummer; A Dendorfer; P Dominiak
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

7.  Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.

Authors:  M A Dalal; A Schuld; M Haack; M Uhr; P Geisler; I Eisensehr; S Noachtar; T Pollmächer
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

8.  Maternal and fetal serum orexin-A levels in gestational diabetes mellitus.

Authors:  Ercan Yilmaz; Onder Celik; Nilufer Celik; Ebru Celik; Ilgin Turkcuoglu; Yavuz Simsek; Yagmur Minareci; Mehmet Boz; Suleyman Aydin
Journal:  J Obstet Gynaecol Res       Date:  2012-08-13       Impact factor: 1.730

9.  Serum orexin-A (OXA) level decreases in polycystic ovarian syndrome.

Authors:  Ercan Yilmaz; Onder Celik; Nilufer Celik; Yavuz Simsek; Ebru Celik; Engin Yildirim
Journal:  Gynecol Endocrinol       Date:  2013-01-25       Impact factor: 2.260

10.  Plasma obestatin and autonomic function are altered in orexin-deficient narcolepsy, but ghrelin is unchanged.

Authors:  M S B Huda; H Mani; B H Durham; T M Dovey; J C G Halford; B S Aditya; J H Pinkney; J P Wilding; I K Hart
Journal:  Endocrine       Date:  2012-11-23       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.